📰 Integrated Data Analysis News
Integrated Data Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Integrated Data Analysis. Real-time updates on events, politics, business and more.
April 11, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic
April 11, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
February 14, 2024
Most phenylephrine products are coformulated with antihistamines or antitussives.
February 10, 2024
But reformulation of products containing OTC 'decongestant' could affect the supply chain
February 9, 2024
A wave of drug supply chain problems would occur if the FDA pulled cough and cold medications containing the active ingredient phenylephrine from shelves; lawmakers in 19 states are considering bills allowing medically assisted death; tuberculosis awareness is lagging as state and local health departments lack the resources to keep up with prevention and control efforts.
February 8, 2024
In the event of administrative removal of these products, clinicians and consumers could substitute oral pseudoephedrine or intranasal decongestants such as phenylephrine or oxymetazoline, the authors say.
July 6, 2023
The government has launched a higher-accuracy voice analysis model aimed at curbing rampant voice phishing scams and other voice-based crimes and plans to share the technology with foreign investigative bodies, a senior interior ministry official said Thursday.
July 6, 2023
The government has launched a higher-accuracy voice analysis model aimed at curbing rampant voice phishing scams and other voice-based crimes and plans to share the technology with foreign investigative bodies, a senior interior ministry official said Thursday. South Korea sees more than 20,000 cases of voice phishing scams every year, wrecking damage worth about 700 billion won (US$537.6 million). A total of more th...
February 16, 2021
email article The last decade saw middle-income countries enjoying improved access to cardiovascular medications, but they remain far from closing the considerable gap with richer countries. Cardiovascular drug sales grew about 10 times faster from 2008 to 2018 in middle-income countries than in high-income countries (annual growth rate 9.96% vs 0.98%), according to a large pharmaceutical sales database probed by Esther Chan, PhD, of the University of Hong Kong, and colleagues. As a resul...